Unknown

Dataset Information

0

Population kinetics of homoarginine and optimized supplementation for cardiovascular risk reduction.


ABSTRACT: Homoarginine is an endogenous amino acid whose levels are reduced in patients with renal, cardio- and cerebrovascular disease. Moreover, low homoarginine concentrations independently predict morbidity and mortality in these patients. Besides endogenous synthesis, homoarginine is also a constituent of the human diet. The objective of the present study was to analyze the kinetics of orally supplemented homoarginine in human plasma by means of a pharmacometric approach. We developed a pharmacometric model to evaluate different dosing regimens, especially the regimen of 125 mg once weekly, based on a previous clinical study (n = 20). The model was adapted to account for differences in baseline homoarginine plasma concentrations between healthy and diseased individuals. A novel dosing regimen of 25 mg once daily led to higher attainment of homoarginine reference concentrations using clinical trial simulations. With 25 mg/day, the trough concentration of only 6% of the older and 3.8% of the younger population was predicted to be below the target concentration of 2.0-4.1 µmol/L. In synopsis, the new dosing regimen recapitulates the kinetics of homoarginine in healthy individuals optimally.

SUBMITTER: Kleist CJ 

PROVIDER: S-EPMC9213336 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Population kinetics of homoarginine and optimized supplementation for cardiovascular risk reduction.

Kleist Christine J CJ   Choe Chi-Un CU   Atzler Dorothee D   Schönhoff Mirjam M   Böger Rainer R   Schwedhelm Edzard E   Wicha Sebastian G SG  

Amino acids 20220526 6


Homoarginine is an endogenous amino acid whose levels are reduced in patients with renal, cardio- and cerebrovascular disease. Moreover, low homoarginine concentrations independently predict morbidity and mortality in these patients. Besides endogenous synthesis, homoarginine is also a constituent of the human diet. The objective of the present study was to analyze the kinetics of orally supplemented homoarginine in human plasma by means of a pharmacometric approach. We developed a pharmacometri  ...[more]

Similar Datasets

| S-EPMC5099544 | biostudies-literature
| S-EPMC5082758 | biostudies-literature
| S-EPMC5813471 | biostudies-literature
| S-EPMC9031005 | biostudies-literature
| S-EPMC8822633 | biostudies-literature
| S-EPMC10203342 | biostudies-literature
| S-EPMC7180827 | biostudies-literature
| PRJEB84474 | ENA
| S-EPMC6768516 | biostudies-literature
| S-EPMC3751579 | biostudies-literature